B.A. (cum laude) in Biochemistry, Olivet College, Olivet, Michigan, 1986. Ph.D. in Biomedical Sciences, Wright State University, Dayton, Ohio, 1991. Postdoctoral fellowship, National Institutes of Health, National Cancer Institute, Frederick, Maryland, 1992-1996. Assistant Professor, The University of Texas at Houston Medical School, Houston, Texas, 1998-2004. Adjunct Assistant Professor, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, 2002-2005. Associate Professor, The University of Texas at Houston Medical School, Houston, Texas, 2004-2005. Professor and Chair, The University of Texas at El Paso, Department of Biological Sciences, 2005-present.

• Office of Research and Sponsored Projects Millionaire Research Award - ORSP (01/01/2018-12/31/2018)
• Office of Research and Sponsored Projects Millionaire Research Award - ORSP (01/01/2017-12/31/2017)
• Office of Research and Sponsored Projects Millionaire Research Award - ORSP (01/01/2016-12/31/2016)
• Office of Research and Sponsored Projects Millionaire Research Award - ORSP (01/01/2015-12/31/2015)
• Office of Research and Sponsored Projects Millionaire Research Award - ORSP (01/01/2014-12/31/2014)
• Outstanding leadership and mentoring - ORSP (01/01/2014-12/31/2014)
• Office of Research and Sponsored Projects Millionaire Research Award - ORSP (01/01/2013-12/31/2013)
• Office of Research and Sponsored Projects Millionaire Research Award - Office of Research and Sponsored Projects (01/01/2012-12/31/2012)
• Office of Research and Sponsored Projects Outstanding Performance Award 2012 - Office of Research and Sponsored Projects (01/01/2012-12/31/2012)
• Symposium Chair Award - BIT's 3rd Annual World DNA and Genome Day (04/27/2012)
• UTEP Office of Research and Sponsored Projects Award for Outstanding Performance in securing Extramural Funding (08/01/2011-08/31/2011)
• Award for Outstanding Performance in Securing Extramural Funding and Faculty Mentoring - UTEP Office of Research and Sponsored Projects (08/31/2010)
• Young Investigator Travel Award - American Society of Transplant Surgeons (01/01/1999-12/31/1999)
• Intramural Research Training Assistantship Award - National Institutes of Health (01/01/1995-12/31/1995)
• Intramural Research Training Assistantship Award - National Institutes of Health (01/01/1994-12/31/1994)
• Intramural Research Training Assistantship Award - National Institutes of Health (01/01/1993-12/31/1993)
• Intramural Research Training Assistantship Award - National Institutes of Health (01/01/1992-12/31/1992)
• Graduate Student Research Lecture Award, Wright State University - Sigma Xi (01/01/1987-12/31/1987)
• Commencement Speaker - Olivet College (01/01/1986-12/31/1986)
• Student Research Award, Olivet College - American Institute of Chemists (01/01/1986-12/31/1986)
• President, Olivet College Chapter of the ACS - American Chemical Society (01/01/1985-12/31/1985)
• Presidential Scholar Award for Academic Excellence - Olivet College (01/01/1985-12/31/1985)
• Student Senate Representative - Olivet College (01/01/1985-12/31/1985)
• Presidential Scholar Award for Academic Excellence - Olivet College (01/01/1984-12/31/1984)
• Student Senate Representative - Olivet College (01/01/1984-12/31/1984)
• Presidential Scholar Award for Academic Excellence - Olivet College (01/01/1983-12/31/1983)
• Presidential Scholar Award for Academic Excellence - Olivet College (01/01/1982-12/31/1982)

• Cytokine Molecular Mechanisms Section, National Institutes of Health/National Cancer Institute (1996)
• Ph D in Biomedical Sciences, Wright State University (1991)
• BA in Biochemistry, Olivet College (1986)

• Phosphorylation of CrkL S114 induced by common gamma chain cytokines and T-cell receptor signal transduction. Scientific Reports 11 1695 (2021), Armando Estrada, Alejandro C. Rodriguez, Georgialina Rodriguez, Alice H. Grant, Yoshira M. Ayala-Marin, Amy J. Arrieta, Robert A. Kirken.
• The Genomic Landscape of a Restricted ALL Cohort from Patients Residing on the U.S./Mexico Border International Journal of Environmental Research and Public Health 18 (2021), Alice Hernandez Grant, Yoshira M. Ayala-Marin, Jonathon E. Mohl, Elisa Robles Escajeda, Georgialina Rodriguez, Julie Dutil, Robert A. Kirken.
• The Many Faces of JAKs and STATs Within the COVID-19 Storm Frontiers in Immunology 12:690477 (2021), Alice H. Grant, Armando Estrada, Yoshira M. Ayala-Marin, America Y. Alvidrez-Camacho, Georgialina Rodriguez, Elisa Robles Escajeda, Denisse A. Cadena-Medina, Alejandro C. Rodriguez, Robert A. Kirken.
• Immunodiagnostic Biomarkers for Hepatocellular Carcinoma (HCC): The First Step in Detection and Treatment. International Journal of Molecular Sciences (2021), Mengtao Xing, Xinzhi Wang, Robert A. Kirken, Ling He, Jian-Ying Zhang.
• Pharmacodynamic biomarkers in metronomic chemotherapy: Multiplex cytokine measurements in gastrointestinal cancer patients Clinical and Experimental Medicine (2020), Paloma Valenzuela, Derrick Oaxaca, Teresa Di Desidero, Karla Parra, Georgialina Rodriguez, Marian M. Manciu, Giacomo Allegrini, Alfredo Falcone, , Guido Bocci, Robert A. Kirken, , Giulio Francia.
• Pharmacodynamic biomarkers in metronomic chemotherapy: multiplex cytokine measurements in gastrointestinal cancer patients Clinical and Experimental Medicine (2020), Paloma Valenzuela, Derrick Oaxaca, Teresa D. Desidero, Robert A. Kirken.
• Bif-1 Interacts with Prohibitin-2 To Regulate Mitochondrial Inner Membrane During Cell Stress and Apoptosis. Journal of the American Society of Nephrology (2019), Robert A. Kirken, S-G. Cho, X. Xiao, X. Wang, H. Gao, R. Rafikov, S. Black, S. Huang, H. Ding, Y. Yoon, X. Yin, H. Wang, Z. Dong.
• Green barley mitigates cytotoxicity in human lymphocytes undergoing aggressive oxidative stress, via activation of both the Lyn/PI3K/Akt and MAPK/ERK pathways. Scientific reports 9 1 (2019), B E. Ruiz-Medina, Daniela Lerma, M Hwang, Jeremy Ross, Rachid Skouta, Renato Aguilera, Robert A. Kirken, A Varela-Ramirez, E Robles-Escajeda.
• Green barley mitigates cytotoxicity in human lymphocytes undergoing aggressive oxidative stress, via activation of both the Lyn/PI3K/Akt and MAPK/ERK pathways. Scientific reports 9 1 (2019), B E. Ruiz-Medina, Daniela Lerma, M Hwang, Jeremy Ross, Rachid Skouta, Renato Aguilera, Robert A. Kirken, A Varela-Ramirez, E Robles-Escajeda.
• Olfactory Receptor Family 7 Subfamily C Member 1 as a potential prognostic marker for pediatric T-cell acute lymphoblastic leukemia patients The FASEB Journal 33 S1 (2019), Haidar Ahmed, Juan S. Espinoza, Dayoung Jeon, Alexia Jauregui, Charles A. Bill, Zachary Parada, David Paz, Alice Hernandez, Robert A. Kirken, Colin A. Bill, Charlotte Vines.
• Integration of a Personalized Molecular Targeted Therapy into the Multimodal Treatment of Refractory Childhood Embryonal Tumor with Multilayered Rosettes (ETMR). Case Reports in Oncology (2019), Robert A. Kirken, L.R. Hartman, D.M. Oaxaca, B. Carcamo, H.L. Wilson, J.A. Ross, E. Robles-Escajeda.
• Integration of a Personalized Molecular Targeted Therapy into the Multimodal Treatment of Refractory Childhood Embryonal Tumor with Multilayered Rosettes (ETMR). Case reports in oncology 12 1 (2019), Hartman LLR, D M. Oaxaca, B Carcamo, Heather Wilson, Jeremy Ross, E Robles-Escajeda, Robert A. Kirken.
• The Research Centers in Minority Institutions (RCMI) Translational Research Network: Building and Sustaining Capacity for Multi-Site Basic Biomedical, Clinical and Behavioral Research (2019), Robert A. Kirken, E.O. Ofili, P.B. Tchounwou, E. Fernandez-Repollet, R. Yanagihara, T.H. Akintobi, J.E. Lee , M. Malouhi, S.T. Garner Jr., T.T. Hayes, A.R. Baker, A.L. Dent, M. Abdelrahim, L. Rollins, S.P. Chang , A. Sy, B.Y. Hernandez , P.L. Bullard, R.J. Noel Jr., B. Shiramizu, J.R. Hedges, M.J. Berry , V.C. Bond, M.F. Lima, N. Mokuau , M. Cruz-Correra , D.F. Sarpong , J. Vadgama, C. Yates, S.A Kahn, K.F. Soliman, G. Perry, M. Pezzano, C.A. Luciano, M.E. Barnett, A. Oyekan, D. Kumar, K.C. Norris.
• Optimization of biomarkers-based classification scores as progression free survival predictors: an intuitive graphical representation Future Science Open Access 4 10 (2018), Marian M. Manciu, Sorour Hosseini, Teresa Desidero, Giacomo Allegrini, Alfredo Falcone, Guido Bocci, Robert A. Kirken, Giulio Francia, , , .
• Optimization of biomarkers-based classification scores as progression free survival predictors: an intuitive graphical representation Future Science Open Access 4 10 (2018), Marian M. Manciu, Sorour Hosseini, Teresa Desidero, Giacomo Allegrini, Alfredo Falcone, Guido Bocci, Robert A. Kirken, Giulio Francia, , , .
• Exploration of Nanoparticle-Mediated Photothermal Effect of TMB-H2O2 Colorimetric System and Its Application in a Visual Quantitative Photothermal Immunoassay. Annals of Chemistry 90 9 (2018), G Fu, S T. Sanjay, W Zhou, R A. Brekken, Robert A. Kirken, X Li.
• Isoproterenol induced beta-2 adrenergic receptor activation negatively regulates interleukin-2 signaling. Biochem J. (2018), B E. Ruiz-Medina, D A. Cadena-Medina, E Esparza, A J. Arrieta, Robert A. Kirken.
• The prohibitin protein complex promotes mitochondrial stabilization and cell survival in hematologic malignancies. Oncotarget 8 39 (2017), Jeremy Ross, E Robles-Escajeda, D M. Oaxaca, D L. Padilla, Robert A. Kirken.
• Impact of CTLA-4 blockade in conjunction with metronomic chemotherapy on preclinical breast cancer growth British Journal of Cancer 116 3 (2017), K Parra, P Valenzuela, N Lerma, A Gallegos, L C. Reza, Georgialina Rodriguez, U Emmenegger, T DiDesidero, G Bocci, M S. Felder, Marian M. Manciu, Robert A. Kirken, Giulio Francia.
• Impact of CTLA-4 blockade in conjunction with metronomic chemotherapy on preclinical breast cancer growth British Journal of Cancer 116 3 (2017), K Parra, P Valenzuela, N Lerma, A Gallegos, L C. Reza, Georgialina Rodriguez, U Emmenegger, T DiDesidero, G Bocci, M S. Felder, Marian M. Manciu, Robert A. Kirken, Giulio Francia.
• Selective Acceleration of CRLF2+Lymphoblast phagocytosis with CD47siRNA-Loaded Anti-CRLF2 Antibody Armored Biodegradable Nanoparticles Advances in Biomedical Engineering 1 2 (2017), S Mahesula, R Raghunathan, A Catala, Robert A. Kirken, K Nash, W E. Haskins.
• The prohibitin protein complex promotes mitochondrial stabilization and cell survival in hematologic malignancies Oncotarget (in press), Jeremy A. Ross, Elisa Robles-Escajeda, Derrick M. Oaxaca, Diana L. Padilla, Robert A. Kirken.
• Impact of CTLA-4 blockade in conjunction with metronomic chemotherapy on preclinical breast cancer growth BRITISH JOURNAL OF CANCER 429 (2016), Karla Parra, Paloma Valenzuela, Natzidielly Lerma, Alejandra Gallegos, Luis C. Reza, Georgiana Rodriguez, Urban Emmenegger, Teresa Di Desidero, Guido Bocci, Mitchell S. Felder, Marian M. Manciu, Robert A. Kirken, Giulio Francia.
• OncoMiner: A Pipeline for Bioinformatics Analysis of Exonic Sequence Variants in Cancer In: Big Data Analytics in Genomics, Wong, K.C. (Ed.), pp.373-396; Springer, New York. Available at doi.org/10.1007/978-3-319-41279-5_12 (2016), Ming-Ying Leung, Joseph A. Knapka, Amy E. Wagler, Georgialina Rodriguez, Robert A. Kirken.
• OncoMiner: A Pipeline for Bioinformatics Analysis of Exonic Sequence Variants in Cancer In: Big Data Analytics in Genomics, Wong, K.C. (Ed.), pp.373-396; Springer, New York. Available at doi.org/10.1007/978-3-319-41279-5_12 (2016), Ming-Ying Leung, Joseph A. Knapka, Amy E. Wagler, Georgialina Rodriguez, Robert A. Kirken.
• Tyrosine Kinase Inhibitors and Phosphatases: Overcoming the BCR-ABL T315I Mutation in CML with a Synergistic Combination of Ponatinib and Forskolin Journal of Clinical and Cellular Immunology (2016), Derrick M. Oaxaca, Sun A. Yang-Reid, Jeremy A. Ross, Joan G. Staniswalis, Robert A. Kirken.
• OncoMiner: A Pipeline for Bioinformatics Analysis of Exonic Sequence Variants in Cancer In: Big Data Analytics in Genomics, Wong, K.C. (Ed.), pp.373-396; Springer, New York. Available at http://link.springer.com/chapter/10.1007/978-3-319-41279-5_12; NIHMSID: 830712 (2016), Ming-Ying Leung, Joseph A. Knapka, Amy E. Wagler, Georgialina Rodriguez, Robert A. Kirken.
• OncoMiner Pipeline for Bioinformatics Analysis of Cancer Gene Mutations Available at http://oncominer.utep.edu. Accessed 12/8/2018 (2016), Ming-Ying Leung, Joseph A. Knapka, Amy E. Wagler, Georgialina Rodriguez, Robert A. Kirken.
• Sensitivity of imatinib-resistant T315I BCR-ABL CML to a synergistic combination of ponatinib and forskolin treatment. Tumor Biology (in press), Derrick M. Oaxaca, Sun A. Yang-Reid, Jeremy A. Ross, Georgialina Rodriguez, Joan G. Staniswalis, Robert A. Kirken.
• Transforming mutations of Jak3 (A573V and M511I) show differential sensitivity to selective Jak3 inhibitors. Clinical Cancer Drugs 3 2 (in press), G. S. Martinez, Jeremy A. Ross, Robert A. Kirken.

• JAK3: Past, Present, and Future (2021), Volume New Mexico State University, Robert A. Kirken.
• COVID Q & A (2021), Volume El Paso, TX, USA, Chuan Xiao, Robert , Manuel Llano, Keith H. Pannell.
• Optimization of biomarkers-based classification scores as Progression Free Survival predictors: An intuitive graphical representation (2018), Volume Grand Rapids, Michigan, Marcos Amendariz, Karla Parra, Paloma Valenzuela, Sorour Hosseini, Teresa Di Desidero, Giacomo Allegrini, Alfredo Falcone, Guido Bocci, Robert A. Kirken, Giulio Francia, Marian M. Manciu.
• Optimization of biomarkers-based classification scores as Progression Free Survival predictors: An intuitive graphical representation (2018), Volume Grand Rapids, Michigan, Marcos Amendariz, Karla Parra, Paloma Valenzuela, Sorour Hosseini, Teresa Di Desidero, Giacomo Allegrini, Alfredo Falcone, Guido Bocci, Robert A. Kirken, Giulio Francia, Marian M. Manciu.
• Impact of CTLA-4 blockade in conjunction with metronomic chemotherapy on preclinical breast cancer growth (2016), Volume New Orleans, Loisiana, Giulio Francia, Karla Parra, Paloma Valenzuela, Alejandra E. Gallegos, Natzidielli Lerma, Luis Reza, Georgialina Rodriguez, Urban Emmenegger, Marian M. Manciu, Teresa Di Desiderio, Guido Bocci, Mitchell S. Felder, Robert A. Kirken.

• Implementing Community-based Approaches to Increase SARS-CoV-2 Testing among an Underserved and Vulnerable Hispanic Population
• BBRC Bridge Funding
• Border Biomedical Research Center - Research Infrastructure Core (RIC)
• Therapeutic strategies to treat high risk relapse childhood cancer
• Border Biomedical Research Center
• Therapeutic strategies for the treatment of cancer and other diseases